Ophthalmology

Dr Rajesh Rajpal on the Future of Eye Lens Technology, Cataract Surgery

September 24th 2021, 3:00pm

Video

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, addresses ongoing and future innovations in eye lens technology and instruments for cataract surgery.

Development of Myopia Found to Accelerate in Young Schoolchildren Amid Pandemic

September 20th 2021, 6:00pm

Article

Incidence and risk of myopia development were found to rise significantly among young Chinese schoolchildren who were exposed to environmental changes caused by COVID-19 between grades 2 to 3.

Ophthalmology Overview: Training With Virtual Reality, Refractive Error in Children, and More

September 17th 2021, 1:30pm

Article

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Comorbid Ophthalmic, Systemic Conditions Linked With Higher Risk of Dementia

September 15th 2021, 4:30pm

Article

People with both ophthalmic and systemic conditions were found to be at higher risk of dementia compared with those with only 1 such condition. Some ophthalmic conditions—age-related macular degeneration, cataract, and diabetes-related eye disease—also increased risk on their own.

Dr Rajesh Rajpal Reviews Latest Innovations in Cataract Surgery

September 11th 2021, 3:30pm

Video

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the surgical options available to patients undergoing cataract surgery.

School-Based Vision Program Shown to Improve Short-term Academic Performance in Adolescents

September 10th 2021, 6:15pm

Article

Students in grades 3 to 7 who were given eyeglasses as part of a school-based vision program were found to achieve better reading scores and exhibit improved academic achievement over 1 year.

Ophthalmology Overview: Managing a Practice, Weight Loss Lessens Risk of Cataract, and More

September 2nd 2021, 2:30pm

Article

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Study Finds Increased Dosage of Timolol-Dorzolamide Fixed Combination Safe, Effective in Open-Angle Glaucoma

August 31st 2021, 4:45pm

Article

Increasing the dosage of timolol-dorzolamide fixed combination from twice a day to 3 times a day was found to be safe and significantly more effective in reducing intraocular pressure in patients with open-angle glaucoma, although further research on safety may be warranted.

Dr Rajesh Rajpal on Eye Health Implications of Visual Needs in Younger Populations

August 27th 2021, 5:30pm

Video

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.

Study Finds Significant Glaucoma Surgery, Mortality Risk Link in Elderly Patients

August 25th 2021, 3:35pm

Article

Elderly patients who underwent surgery for glaucoma had a greater risk of all-cause and cause-specific mortality than those who did not have surgery, including greater risk of cancer and neurologic cause–related mortality.